Completed PHASE3 INTERVENTIONAL 1-arm NCT00123318

A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer

Sponsor: The Royal Australian and New Zealand College of Radiologists

Interventions 5-fluorouracil Radiotherapy cisplatin epirubicin

Updated 5 times since 2017 Last updated: Jun 17, 2013 Started: Feb 28, 2003 Primary completion: Feb 29, 2012 Completion: Feb 29, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Gastric Cancer and is currently completed. The Royal Australian and New Zealand College of Radiologists leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Royal Australian and New Zealand College of Radiologists
Trans Tasman Radiation Oncology Group

Data source: Trans Tasman Radiation Oncology Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Box Hill, Australia , Brisbane, Australia , Christchurch, New Zealand , Geelong, Australia , Herston, Australia , Launceston, Australia , Liverpool, Australia , Melbourne, Australia , Newcastle, Australia , Penrith, Australia and 6 more locations